How to Plan for the Obesity Drug Revolution

[Northeast Agent]

How to Plan for the Obesity Drug Revolution | ThinkAdvisor

Life insurers and their reinsurers are starting to think about what Wegovy, Saxenda and successors could do for your clients.

www.thinkadvisor.com

Insurers and their reinsurers have seen enthusiasm about weight-loss wonder drugs come and go for decades, but now medical experts at Gen Re, Reinsurance Group of America, Munich Re, Scor and Swiss Re are starting let their guard down and wonder what might happen if the GLP-1 agonists really work, and keep working.

 

[Allen Trent]

How to Plan for the Obesity Drug Revolution | ThinkAdvisor

Life insurers and their reinsurers are starting to think about what Wegovy, Saxenda and successors could do for your clients.

www.thinkadvisor.com

Insurers and their reinsurers have seen enthusiasm about weight-loss wonder drugs come and go for decades, but now medical experts at Gen Re, Reinsurance Group of America, Munich Re, Scor and Swiss Re are starting let their guard down and wonder what might happen if the GLP-1 agonists really work, and keep working.

I don't know. Seeing lots of kidney failure connected to some of those drugs. Also, Dr friend's say 30-40% of the weight loss is loss of muscle mass & when the drug is stopped, the weight comes back but not the muscle mass

https://www.sciencedirect.com/science/article/pii/S2590059520302697

Weight-loss drugs like Ozempic and Wedovy may be risky for older people because they melt away all-important muscles, experts say

About a quarter of weight loss is typically from the loss of lean mass, like muscle and bone, which is essential for metabolism and preventing injury as we age.

fortune.com